Should we use rifampicin in periprosthetic joint infections caused by staphylococci when the implant has been exchanged? A multicenter observational cohort study

Kramer, Tobias Siegfried; Soriano, Alex; Tedeschi, Sarah; Chen, Antonia F.; Tattevin, Pierre; Senneville, Eric; Gómez Junyent, Joan; Birlutiu, Victoria; Petersdorf, Sabine; Diaz de Brito, Vicens; Sancho González, Ignacio; Belden, Katherine A.; Wouthuyzen-Bakker, Marjan

Home
→
Recerca: articles, congressos, llibres
→
Departament de Medicina i Ciències de la Vida
→
Articles (Departament de Medicina i Ciències de la Vida)
→
View Item

Should we use rifampicin in periprosthetic joint infections caused by staphylococci when the implant has been exchanged? A multicenter observational cohort study

Document Type: Article

Version: Published version

Date: 2024

This document is associated with a Creative Common license

© The Author(s) 2024. Published by Oxford University Press on behalf of Infectious Diseases Society of America. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.

Name: Kramer_ofi_shou.pdf

Size: 584.4Kb

Format: PDF

View/Open

Citation: Kramer TS, Soriano A, Tedeschi S, Chen AF, Tattevin P, Senneville E, et al. Should we use rifampicin in periprosthetic joint infections caused by staphylococci when the implant has been exchanged? A multicenter observational cohort study. Open Forum Infect Dis. 2024 Feb 8;11(3):ofae075. DOI: 10.1093/ofid/ofae075

Permanent link: http://hdl.handle.net/10230/59833